Linklaters advised RoboSense Technology Co., Ltd (RoboSense) on the deal. RoboSense Technology Co., Ltd (RoboSense) completed the placing of new shares, raising approximately HK$1bn. This placing...
You must be a Standard 1 Year member to access this content.
Linklaters acted as the Hong Kong and US counsel for the sole sponsor and the underwriters on the global offering. Chifeng Jilong Gold Mining Co., Ltd....
You must be a Standard 1 Year member to access this content.
Linklaters advised Minieye Technology on the IPO. Minieye Technology Co., Ltd (Minieye) completed its HK$606 million global offering and successful listing of H shares on the...
You must be a Standard 1 Year member to access this content.
Linklaters announce a significant expansion of its Greater China corporate and capital markets practices with the addition of: Christine Xu as partner and Head of Greater...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised MicroPort Scientific Corporation on the deal. MicroPort Scientific Corporation, a global medical devices company listed on the Hong Kong Stock Exchange (HKEX), has...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised RoboSense Technology Co., Ltd. Light Detection and Ranging (LiDAR) and perception solutions company RoboSense Technology Co., Ltd completed its initial public offering and listing...
You must be a Standard 1 Year member to access this content.
Clifford Chance has acted for Neusoft Xikang Holding Inc. Neusoft Xikang Holding Inc. raised $81.5 million in its initial public offering (IPO) and priced the shares at...
You must be a Standard 1 Year member to access this content.
Clifford Chance advises Red Star Macalline Holding on the RMB6.3 billion sale of a 29.95% equity interest in Red Star Macalline Group Corporation to Xiamen C&D....
You must be a Standard 1 Year member to access this content.
Clifford Chance advised JF Wealth on the deal. The transaction involved JF Wealth’s US$142 million initial public offering and listing on the mainboard of the Hong Kong...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
You must be a Standard 1 Year member to access this content.
Maples and Calder, together with Skadden, acted for Kanzhun Limited. Clifford Chance advised Morgan Stanley and Goldman Sachs. Morgan Stanley and Goldman Sachs agreed for dual...
You must be a Standard 1 Year member to access this content.
Clifford Chance and JunHe advised cosmetics company Shanghai Chicmax Cosmetic Co., Ltd. on the deal. Freshfields Bruckhaus Deringer advised the joint sponsors. Shanghai Chicmax Cosmetic Co.,...
You must be a Standard 1 Year member to access this content.
